A high-performance hybrid device ideal for users whose snoring is caused by both jaw position and tongue obstruction[cite: 150, 2156].

Zyppah Review: Dual-Action Hybrid Airway Support

Published Mar 21, 2026
|
Reviewed by Dustin Cotliar, MD, MPH, MD
|
Testing 10 days
|
Evidence Moderate Clinical Evidence
PEER REVIEWED

The Zyppah is a 'dual-action' hybrid device that distinguishes itself by simultaneously utilizing mandibular advancement and patented 'tongue band' technology[cite: 150, 463]. While the jaw advancement component opens the airway, the elastic tongue strap acts as a 'seatbelt' to prevent the tongue from falling backward into the throat-addressing the root cause of snoring more comprehensively than single-mechanism devices[cite: 150, 475, 476]. The device was invented by Dr. Jonathan Greenburg, a bioengineer and sleep specialist[cite: 482, 498]. It is manufactured in the USA from medical-grade, BPA-free, and latex-free thermoplastic elastomers[cite: 150, 2157]. Fitting involves a 45-second immersion in hot water followed by a 60-second bite to create a custom impression[cite: 151, 478, 479]. In a peer-reviewed clinical trial, 91% of users reported significant benefits in snoring reduction, though some users may require an acclimation period to overcome the initial gag reflex caused by the tongue strap[cite: 150, 151, 489].

Recommended Moderate Clinical Evidence FDA 510(k) Cleared
ZYPPAH Anti-Snoring Device - Medical Device

ZYPPAH Anti-Snoring Device

Zyppah

$99.95
85 /100

Our Score

Clinical Performance Metrics

Quantitative assessment based on clinical testing protocols

Snoring Reduction

91% of users reported clinical benefits, with significant improvements noted in snoring frequency and severity[cite: 463, 488].

91/100

Wearing Comfort

The tongue strap effectively stabilizes the airway but can trigger a gag reflex or excessive salivation during the initial break-in period[cite: 151, 2461].

78/100

Ease of Use

Uses a standard boil-and-bite fitting process that can be completed in minutes at home[cite: 151, 477].

85/100

Value for Money

Offers a unique hybrid mechanism and high clinical success rates for approximately $100[cite: 463, 464].

86/100

Quick Take

Key findings from our clinical evaluation

+
Strengths

  • Dual-action design targets both jaw position and tongue stabilization [cite: 150, 501]
  • Clinically proven to stop snoring in 91% of users [cite: 463, 489]
  • Made in the USA from medical-grade, BPA-free materials [cite: 150, 2157]
  • 91-day money-back guarantee provides a risk-free trial period [cite: 481, 496]
  • Boil-and-bite customization allows for a personalized fit in minutes [cite: 151, 477]

Limitations

  • Tongue strap may cause an initial gag reflex or discomfort [cite: 151, 2461]
  • Device can cause temporary jaw or muscle soreness [cite: 2006, 2007]
  • Requires multiple nights of adjustment for the tongue to acclimate [cite: 151]

Real-World Usage

Practical considerations for daily operation

Daily Routine Impact

Fits into a nightly routine after a brief break-in period. Users are encouraged to wear the device for 30 minutes to 2 hours while awake to acclimate to the tongue strap[cite: 2006].

Learning Curve

Comfortable within a week

Maintenance

Daily cleaning with mild soap and cool water is necessary to maintain hygiene and device integrity[cite: 356, 412].

Portability

High; lightweight and compact design includes a ventilated storage case[cite: 2157].

Manual Use

Purely mechanical device that requires manual boil-and-bite molding but no ongoing digital calibration.

Cost & Coverage Analysis

Financial considerations and HSA / FSA eligibility

Pricing Breakdown

Device Price $99.95
Replacement Mouthpiece (Single replacement hybrid oral appliance)
$99.95 / yearly
Cleaning Tablets (Antibacterial or denture-style cleaning tablets)
$15.00 / quarterly
HSA / FSA Eligibility Rarely Eligible

HSA/FSA Guidance

Device is HSA/FSA eligible; users can use health benefits to cover the cost[cite: 445, 501].

Cost Comparison

Competitively priced around $100, which is higher than basic MADs but reflective of its hybrid technology[cite: 464, 472].

Patient Suitability

Clinical indications and contraindications

Indicated For

  • Snorers whose primary issue is tongue-base obstruction [cite: 475, 476]
  • Users seeking a clinically validated hybrid solution [cite: 150, 482]
  • Individuals who have found single-mechanism MADs ineffective [cite: 150]

Contraindications

  • Patients with severe respiratory issues or sleep apnea [cite: 2465]
  • Individuals with a highly sensitive gag reflex [cite: 151, 2461]

Age Considerations

Intended for use in adults 18 years of age and older[cite: 2002].

Clinical Efficacy Assessment

Evidence-based evaluation of clinical performance

Snoring Frequency Reduction

Measures the percentage reduction in snoring episodes recorded overnight.

Clinical results showed a 57% reduction in snoring frequency among test subjects[cite: 488].

Sleep Quality Improvement

Assess improvement in restorative sleep and reduction in daytime fatigue.

91% of users reported overall sleep benefits and improved morning alertness[cite: 489, 490].

AHI Improvement (if applicable)

Measures the reduction in the Apnea-Hypopnea Index (AHI) for OSA patients.

The device is specifically designed for snoring reduction and is not intended to treat sleep apnea[cite: 2464, 2465].

Partner-Reported Improvement

Evaluates the impact of the device on the bed partner's sleep environment.

60% of partners reported a significant improvement in their own sleep experience[cite: 488].

Comparative Performance

Ranked #15 of 20 clinically evaluated anti-snoring devices devices

1
ProSomnus EVO Sleep and Snore Device

ProSomnus EVO Sleep and Snore Device

ProSomnus

Top Rated
2
Panthera Classic (D-SAD)

Panthera Classic (D-SAD)

Panthera Dental

3
ZQuiet Anti-Snoring Mouthpiece

ZQuiet Anti-Snoring Mouthpiece

ZQuiet

15
ZYPPAH Anti-Snoring Device

ZYPPAH Anti-Snoring Device

Zyppah

You're viewing this
85 /100

Clinical Context

Our #1-ranked anti-snoring devices device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.

Clinical Recommendation

Final assessment and prescribing guidance

The Zyppah is an exceptionally effective anti-snoring device for users who can acclimate to the tongue strap. Its unique hybrid mechanism offers a higher probability of success by stabilizing both the jaw and the tongue.

Recommend If

You want a clinically backed device that addresses snoring from multiple anatomical angles and you are comfortable with an initial acclimation period for your tongue.

Avoid If

You have a severe gag reflex or require a device specifically cleared for medical treatment of sleep apnea.

Clinical Summary

85 /100

Composite Score

Recommended

Recommendation

$100

Price Point

Evidence: Moderate
Tested: 10 days

Where to Buy

Verified purchase options and current availability

Zyppah, Inc.

Price: $99.95
Standard shipping available

91-day money-back guarantee; HSA/FSA eligible; Made in the USA[cite: 43, 44, 103].

Shop Now

Sleep Doctor

Price: $99.95
1-2 business days

Top pick for tongue stabilization; FSA/HSA eligible[cite: 907, 1382].

Shop Now

Important Information

  • • Prices and availability subject to change
  • • Some devices may require a prescription
  • • HSA / FSA eligibility: Rarely Eligible
  • • Purchase from authorized retailers for warranty protection
Visit Manufacturer Website
Testing Methodology

A peer-reviewed clinical study involving 570 habitual snorers who completed symptom questionnaires after 10 days of device use[cite: 487, 488].

Medical Review: Clinical evaluators note that the Zyppah targets the tongue specifically, which is a primary cause of airway obstruction, without requiring excessive mandibular repositioning[cite: 491, 492].

Medical Disclaimer

This review is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with healthcare professionals before making medical device decisions. Clinical recommendations should be individualized based on patient-specific factors.